 Sarcoma
"Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Descriptor ID |
D012509
|
| MeSH Number(s) |
C04.557.450.795
|
| Concept/Terms |
Sarcoma- Sarcoma
- Sarcomas
- Sarcoma, Soft Tissue
- Sarcomas, Soft Tissue
- Soft Tissue Sarcoma
- Soft Tissue Sarcomas
Sarcoma, Epithelioid- Sarcoma, Epithelioid
- Epithelioid Sarcoma
- Epithelioid Sarcomas
- Sarcomas, Epithelioid
Sarcoma, Spindle Cell- Sarcoma, Spindle Cell
- Sarcomas, Spindle Cell
- Spindle Cell Sarcoma
- Spindle Cell Sarcomas
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma".
This graph shows the total number of publications written about "Sarcoma" by people in this website by year, and whether "Sarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 1 | 4 | | 1995 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 2 | 0 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 4 | 0 | 4 | | 2010 | 2 | 0 | 2 | | 2011 | 1 | 0 | 1 | | 2012 | 1 | 1 | 2 | | 2013 | 7 | 0 | 7 | | 2014 | 4 | 0 | 4 | | 2015 | 6 | 2 | 8 | | 2016 | 9 | 0 | 9 | | 2017 | 5 | 1 | 6 | | 2018 | 10 | 0 | 10 | | 2019 | 3 | 0 | 3 | | 2020 | 7 | 0 | 7 | | 2021 | 8 | 0 | 8 | | 2022 | 6 | 0 | 6 | | 2023 | 6 | 0 | 6 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sarcoma" by people in Profiles.
-
Black JO, Al-Ibraheemi A, Arnold MA, Coffin CM, Davis JL, Parham DM, Rudzinski ER, Shenoy A, Surrey LF, Tan SY, Spunt SL. The Pathologic Diagnosis of Pediatric Soft Tissue Tumors in the Era of Molecular Medicine: The Sarcoma Pediatric Pathology Research Interest Group Perspective. Arch Pathol Lab Med. 2024 Jan 01; 148(1):107-116.
-
Rolfes PS, Yoeli D, Feldman AG, Adams MA, Wachs ME, Boster JM. Modern-era successful liver transplantation outcomes in children with hepatic undifferentiated embryonal sarcoma. Pediatr Transplant. 2024 Feb; 28(1):e14645.
-
Jeyabal P, Bhagat A, Wang F, Roth M, Livingston JA, Gilchrist SC, Banchs J, Hildebrandt MAT, Chandra J, Deswal A, Koutroumpakis E, Wang J, Daw NC, Honey TA, Kleinerman ES. Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clin Cancer Res. 2023 11 01; 29(21):4430-4440.
-
M?ller JA, Delank KS, Laudner K, Wittenberg I, Zeh A, Vordermark D, Medenwald D. Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry. J Cancer Res Clin Oncol. 2023 Dec; 149(19):17051-17069.
-
Gestrich CK, Davis JL, Biederman L, John I, Alaggio R, Giovannoni I, Arnold MA, Shenoy A, Tchakarov A, Al-Ibraheemi A. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors. Mod Pathol. 2023 Dec; 36(12):100334.
-
Weiss AR, Chen YL, Scharschmidt TJ, Xue W, Gao Z, Black JO, Choy E, Davis JL, Fanburg-Smith JC, Kao SC, Kayton ML, Kessel S, Lim R, Million L, Okuno SH, Ostrenga A, Parisi MT, Pryma DA, Randall RL, Rosen MA, Shulkin BL, Terezakis S, Venkatramani R, Zambrano E, Wang D, Hawkins DS, Spunt SL. Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology. J Clin Oncol. 2023 11 01; 41(31):4842-4848.
-
McLean-Thomas L, Gao D, Trenbeath Z, Cost CR, Milgrom SA. Equivocal end-of-therapy imaging findings do not predict a higher risk of local relapse after definitive radiotherapy in pediatric Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer. 2023 05; 70(5):e29989.
-
Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD. A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2?and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery. Eur J Cancer. 2022 11; 176:155-163.
-
Stacchiotti S, Maria Frezza A, Demetri GD, Blay JY, Bajpai J, Baldi GG, Baldini EH, Benjamin RS, Bonvalot S, Bov?e JVMG, Callegaro D, Casali PG, D'Angelo SP, Davis EJ, Dei Tos AP, Demicco EG, Desai J, Dileo P, Eriksson M, Gelderblom H, George S, Gladdy RA, Gounder MM, Gupta AA, Haas R, Hayes A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Maestro R, Martin Broto J, Maki RG, Miah AB, Palmerini E, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Strauss SJ, Tap WD, Thomas DM, Trama A, Trent JC, van der Graaf WTA, van Houdt WJ, von Mehren M, Wilky BA, Fletcher CDM, Gronchi A, Miceli R, Wagner AJ. Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments. Cancer Treat Rev. 2022 Nov; 110:102455.
-
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A. Immunotherapy in Sarcoma: Where Do Things Stand? Surg Oncol Clin N Am. 2022 07; 31(3):381-397.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|